I appreciate the courtesy of Kusumoto at NCC for this presentation. What is Early Lung Cancers. Early Lung Cancers. Early Lung Cancers 18/10/55
|
|
- Annabel Mathews
- 5 years ago
- Views:
Transcription
1 I appreciate the courtesy of Kusumoto at NCC for this presentation. Dr. What is Early Lung Cancers DEATH Early period in its lifetime Curative period in its lifetime Early Lung Cancers Early Lung Cancers Considerable long-term survival is available by the appropriate treatments Japanese pulmonologists, thoracic surgeons, pathologists, radiation oncologists, and thoracic diagnostic radiologists manage the patients with lung cancer subject to this general rule. Definition of early hilar or central lung cancers (A) Clinical Criteria 1) There are no radiological abnormal findings including CT, tomography and chest radiographs. 2) There are no lymph nodes and distant metastases on conventional radiological modalities. (B) Endoscopical Criteria 1) Localized from trachea to sub-segmental bronchi 2) Distal margin of the lesion can be identified 3) The diameter in long axis is equal or less than 2.0 cm 4) Histopathologically squamous cell carcinoma General Rule for clinical and pathological record of lung cancer The 7 th edition Nov 2010 by The Japan Lung Cancer Society Definition of early hilar or central lung cancers (A) Clinical Criteria 1) There are no radiological abnormal findings including CT, tomography and chest radiographs. 2) There are no lymph nodes and distant metastases on conventional radiological modalities. (B) Endoscopical Criteria 1) Localized from trachea to sub-segmental bronchi 2) Distal margin of the lesion can be identified 3) The diameter in long axis is equal or less than 2.0 cm 4) Histopathologically squamous cell carcinoma General Rule for clinical and pathological record of lung cancer The 7 th edition Nov 2010 by The Japan Lung Cancer Society 1
2 Long-term survival of early hilar or central lung cancers Definition of early peripheral lung cancers The 5-year survival 100% n=27 Watanabe Y, et al. J Surg Oncol 48:875-80, % n=26 Terzi A, et al. Lung Cancer 27: The 10-year survival No definition 92% n=27 Watanabe Y, et al. J Surg Oncol 48:875-80, 1991 General Rule for clinical and pathological record of lung cancer The 7 th edition Nov 2010 by The Japan Lung Cancer Society HRCT findings of small peripheral lung cancers 100% ground glass attenuation (pure GGA): non-solid nodule pure ground glass nodule (pure GGN) ground glass attenuation and solid component (part-solid nodule or semi-solid nodule) subsolid nodule: pure GGA and part-solid nodule solid nodule Travis WD, et al: International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 6: , The New Pathological classification of small adenocarcinomas Atypical adenomatous hyperplasia (AAH) Adenocarcimona in situ (AIS) Minimally invasive adenocarcinoma (MIA) Lepidic predominant adenocarcinoma (LPA) Acinar PA Papillary and micropapillary PA Solid PA Mucinous adenocarcinoma Colloid adenocacimona, etc. No BAC Bronchioloalveolar carcinoma Travis WD, et al: International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 6: , The New Pathological classification of small adenocarcinomas Atypical adenomatous hyperplasia (AAH) Adenocarcimona in situ (AIS) Minimally invasive adenocarcinoma (MIA) Lepidic predominant adenocarcinoma (LPA) Acinar PA Papillary and micropapillary PA Solid PA Mucinous adenocarcinoma Colloid adenocacimona, etc. Travis WD, et al: International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 6: , The New Pathological classification of small adenocarcinomas Pure GGN Part-solid nodule Atypical adenomatous hyperplasia (AAH) Adenocarcimona in situ (AIS) Minimally invasive adenocarcinoma (MIA) Lepidic predominant adenocarcinoma (LPA) Acinar PA Papillary and micropapillary PA Solid PA Mucinous adenocarcinoma Colloid adenocacimona, etc. Solid nodule Variants Travis WD, et al: International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 6: ,
3 To Find Early Lung Cancers Earlier Detection might be Effective? Radiograph and Cytology? Fontana RS, et al. Chest 67: , 1991 Oken MM, et al. JAMA 306, , 2011 Low-Dose CT Screening Lung cancer low-dose CT Screening Bach PB, et al. JAMA 2007; 297: increased cases, no mortality change VS. Henschke CI, et al. NEJM 2006; 355: increased early stage %, extended 5-year survival NLST RT. NEJM 2011; 365: heavy smoker (at least 30 pack years) 20% reduction in mortality Dutch-Belgian NELSON Trial Italung-CT Trial ongoing Lung cancer low-dose CT Screening NLST RT. NEJM 2011; 365: heavy smoker (at least 30 pack years) 20% reduction in mortality Smoking rate has been decreasing Thailand 22.5% 18.1% Japan 33.7% 23.9% USA 16.1% France 26.2% F: 10% M: 36% My personal experience Between 1999 and 2007 At one screening institution 1500 examinees per year (with; 60% and without; 40% smoking) LDCT (7mm gapless) I interpreted all exams Many pure GGNs and part-solid nodules showing excellent prognosis My personal experience My outpatient service quickly filled to over flowing On 2007, the institution was closed by the reformation by prime minister Jun-ichiro Koizumi Even now I still have some?patients? (with no symptom, only GGN) at my outpatient division I never wish to start a new LDCT screening program again My personal experience First 2 years results 7/1320 (530/100,000) among smokers 2 Sq, 4 Ad and 1 unknown 2/830 (240/100,000) no smokers 2 Ad (pure GGN) Stage IA (78%), IB (11%), IV (11%) Normal 33%, Follow-up 30% 21% of all participants resulted in POSITIVE on CT (3 rd year 9%) 2 thymomas, 1 thyroid ca, 6 pneumonias, 4 IP, each 2 benign tumors, Tb and ectasis 3
4 Harms of LDCT screening A lot of cases with False Positive Cancer panic syndrome Long term follow up with CT resulting in high dose protocol low cost performance Time Swenson consuming SJ, et al. Lung cancer screening for with Pts CT: Mayo and clinic experience. MDs Radiology 226: , 2003 Benefit of early detection: mortality Lead-time bias with symptoms without symptoms Length bias low-grade malig. only Overdiagnosis bias not COD malig insignificant cancers HRCT findings of small peripheral lung cancers 49-year-old Man with a Pure GGN pure ground glass nodule (pure GGN) Mostly round localized GGN 75% AIS 6% AAH 19% Organizing P/Fibrosis Kim HY, et al. Radiology 245: , 2007 AIS: Noguchi type A 57-year-old Man with a Pure GGN 57-year-old Man with a Pure GGN T1WI T2WI CE-T1WI Atypical adenomatous hyperplasia (AAH) Rt. S2,10x8 mm GGA 100% dynamic MRI 4
5 57-year-old Man with a Pure GGN 46-year-old Woman with a Pure GGN FDG-PET coronal (MPR coronal) AIS, Noguchi type B (MPR sagittal) 46-y-o Woman Pure GGN Dynamic CE-MRI T2WI T1WI CE-T1WI MRI 46-year-old Woman with a Pure GGN FDG-PET MIA, Noguchi type C 0.4 5
6 Adenocarcinoma in situ: AIS Are these pure GGNs really the early lung cancer? CT: 18 mm in diameter, inhomogeneous GGN tiny high attenuation spots Pathological findings: non-invasive adenocarcinoma inhomogeneous collapse and fibrotic area Woman in her 60s Found on CT screening High attenuation Pure GGN Woman in her 50s Incidentaloma Irregular shaped Pure GGN A case with a Pure GGN: follow-up A case with pure GGN: follow-up, 69-year-old May 2001 (43-y-o) May 2007 (6-y later: 49-y-o) Nov 2001 May 2002 Mar
7 61-year-old Woman (never smoker) Pure GGN 72-year-old Man with a Pure GGN 4 years later HRCT 72-year-old Man with a Pure GGN 72-year-old Man with a Pure GGN T1WI MRI T2WI CE-T1WI late phase Dynamic CE MIA localized interstitial fibrosis Pure GGNs Mostly round localized GGN 75% AIS 6% AAH 19% OP/Fibrosis Kim HY, et al. Radiology 245: , 2007 Hara M, et al. Radiat Med 20:93-95, 2002 A round shape means AAH or AIS Most of cases will enlarge very slowly Surgical procedure might not be the first choice Pure GGNs might remain early status during a very long period There would be a few cases showing an interval enlargement 7
8 HRCT findings of small peripheral lung cancers 59-year-old Man with a Part-solid nodule ground glass attenuation and solid component (part-solid nodule or semi-solid nodule) solid component within GGN to some extent not always round shape relatively high attenuation GGN Travis WD, et al: International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 6: , Minimally invasive adenocarcinoma (Noguchi type C) 62-year-old Man with a Part-solid nodule Minimally invasive adenocarcinoma: MIA Lepidic predominant adenocarcinoma (Noguchi type C) CT: 15 mm in long axis, part-solid nodule, 7 mm solid component Pathological findings: Lepidic proliferation 3 mm fibroblast proliferation Invasive adenocarcinoma lepidic pattern predominant: LPA Invasive adenocarcinoma lepidic pattern predominant: LPA CT: 14 mm in long axis, pure GGN Pathological findings: Lepidic proliferation, central papillary proliferation CT: 20 mm in long axis, part-solid nodule 7 mm solid component at the marginal region of the lesion Pathological findings: Lepidic proliferation, 10 x 10 mm central fibrotic area 8
9 65-year-old Woman with a Part-solid nodule (T2a) 65-year-old Woman with a Part-solid nodule (T2a) HRCT T1WI MRI T2WI CE-T1WI 65-year-old Woman with a Part-solid nodule (T2a) 65-year-old Woman with a Part-solid nodule (T2a) Dynamic CE MIA FDG-PET 65-year-old Woman with a Part-solid nodule (T2a) Minimally Invasive Adenocarcinoma(T1b) Macroscopic finding 9
10 54-year-old Man with a Part-solid nodule (T1a) 54-year-old Man with a Part-solid nodule (T1a) T1WI HRCT MRI T2WI CE-T1WI 54-year-old Man with a Part-solid nodule (T1a) Minimally Invasive Adenocarcinoma(T1b) Dynamic CE Woman in her 80s Left pleural effusion Incidentaloma Part-solid nodule Woman in her 70s with bladder ca. Incidentaloma Part-solid nodule 10
11 54-year-old man with a Part-solid nodule 2 months later 43-year-old Man with a Part-solid nodule HRCT findings of small peripheral lung cancers solid component alone (solid nodule) Tuberculosis On HRCT distinct border, irregular margin, spicula, and pleural indentation etc. lobulation round shape long and narrow along with bronchiole Travis WD, et al: International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 6: , year-old Man with a tiny Solid nodule Correlation the CT finding with pathological one - 5-year survival and surgical technique - Adenocarcimona (2cm and less, n=175) pathological finding CT finding non-invasive invasive Pure GGN Part-solid nodule (GGA 50% or more) 100% Wedge resection 100% Wedge resection 93.4% Segmentectomy Acinar PA Noguchi type E Solid nodule 100% Wedge resection 79.1% Lobectomy NCC Thoracic Surgery, Suzuki K, et al. 11
12 56-year-old Man (smoker) with a Solid nodule How about Sq CCs and Sm CCs? severe emphysema 3 mm reconstruction thickness, NDCT (Oct 2004) A 12x8 mm Solid nodule in his upper lobe (S1+2a) Found on LDCT (20 months before: 10x8 mm) Interval enlargement was observed compared to the previous CT (6 months before) 56-year-old Man (smoker) with a Solid nodule 65-year-old Man (smoker) with a Solid nodule Oct 2004 FDG-PET Mar mm reconstruction thickness 10x8 mm on CT homogeneously enhanced FDG-PET 20 months before shows a faint uptake Moderately Differentiated Sq CC (T1aN0M0) 2009 follow-up was terminated without recurrences (still heavy smoker) 2010 a new oropharyngeal ca. (Sq CC) was found Screening CT 1 month later 3 months later Small Cell Lung Cancer 70-year-old Man with a tiny Solid nodule Small cell lung cancers show rapid progression and it would be hard to find them in early stage on screening CT The other aggressive cancers are as well Stage I small cell lung cancers are exceptionally experienced that can be resected by chance Tuberculoma Screening CT 6 months later 12
13 80-year-old Man (smoker) with a Solid nodule 69-year-old Woman (non-smoker) with a Solid nodule showing shaggy margin 1 year and 6 months later 3 months later HRCT findings of small peripheral lung cancers Multiple adenocarcinomas SUV 1.1 SUV 1.3 Rt. S1,GGA 80% 25x20 mm MIA, WD ad ca Rt. S2,GGA 20% 15x12 mm MIA, WD ad ca SUV year-old Man with triple cancers Rt. S6,GGA 75% 14x10 mm MIA, WD ad ca Rt. S2,GGA 50% 37x34 mm, LPA 61-year-old Woman with double cancers FDG-PET coronal Noguchi C type GGA 50% 64-y-o Woman double cancers PET spot SUV 0.6 Poorly D. Ad ca SUV 0.8 Rt. S9,pure GGN 15x11 mm, AIS 13
14 64-y-o Woman with double cancers SUV 4.3 P.D. ad ca LN metastasis SUV 3.8 TP LN metastasis SUV 3.9 TP The differential diagnosis for small solid nodules might sometimes become very difficult SUV 1.0 Noguchi C type, GGA 50% Definition of early peripheral lung cancers Adenocarcinoma Pure GGNs (AIS) Part-solid nodules (MIA and LPA) Keep being an early stage during pts life and require no treatments Keep being an early stage during long period and can be diagnosed on CT Solid nodules There might be some cases and may be checked on CT Squamous cell carcinoma Small cell carcinoma There might be some cases and may be checked on CT Early cases may be hard to be found on CT Smokers 14
Thoracic CT pattern in lung cancer: correlation of CT and pathologic diagnosis
19 th Congress of APSR PG of Lung Cancer (ESAP): Update of Lung Cancer Thoracic CT pattern in lung cancer: correlation of CT and pathologic diagnosis Kazuma Kishi, M.D. Department of Respiratory Medicine,
More informationThe Spectrum of Management of Pulmonary Ground Glass Nodules
The Spectrum of Management of Pulmonary Ground Glass Nodules Stanley S Siegelman CT Society 10/26/2011 No financial disclosures. Noguchi M et al. Cancer 75: 2844-2852, 1995. 236 surgically resected peripheral
More informationPulmonary Nodules & Masses
Pulmonary Nodules & Masses A Diagnostic Approach Heber MacMahon The University of Chicago Department of Radiology Disclosure Information Consultant for Riverain Technology Minor equity in Hologic Royalties
More informationOBJECTIVES. Solitary Solid Spiculated Nodule. What would you do next? Case Based Discussion: State of the Art Management of Lung Nodules.
Organ Imaging : September 25 2015 OBJECTIVES Case Based Discussion: State of the Art Management of Lung Nodules Dr. Elsie T. Nguyen Dr. Kazuhiro Yasufuku 1. To review guidelines for follow up and management
More informationThe 2015 World Health Organization Classification for Lung Adenocarcinomas: A Practical Approach
The 2015 World Health Organization Classification for Lung Adenocarcinomas: A Practical Approach Dr. Carol Farver Director, Pulmonary Pathology Pathology and Laboratory Medicine Institute Objectives Discuss
More informationGround Glass Opacities
Ground Glass Opacities A pathologist s perspective Marie-Christine Aubry, M.D. Professor of Pathology Mayo Clinic Objectives Discuss the proposed new pathologic classification of adenocarcinoma with historical
More informationLUNG NODULES: MODERN MANAGEMENT STRATEGIES
Department of Radiology LUNG NODULES: MODERN MANAGEMENT STRATEGIES Christian J. Herold M.D. Department of Biomedical Imaging and Image-guided Therapy Medical University of Vienna Vienna, Austria Pulmonary
More informationPULMONARY NODULES AND MASSES : DIAGNOSTIC APPROACH AND NEW MANAGEMENT GUIDELINES. https://tinyurl.com/hmpn2018
PULMONARY NODULES AND MASSES : DIAGNOSTIC APPROACH AND NEW MANAGEMENT GUIDELINES Heber MacMahon MB, BCh Department of Radiology The University of Chicago https://tinyurl.com/hmpn2018 Disclosures Consultant
More informationXiaohuan Pan 1,2 *, Xinguan Yang 1,2 *, Jingxu Li 1,2, Xiao Dong 1,2, Jianxing He 2,3, Yubao Guan 1,2. Original Article
Original Article Is a 5-mm diameter an appropriate cut-off value for the diagnosis of atypical adenomatous hyperplasia and adenocarcinoma in situ on chest computed tomography and pathological examination?
More informationThe small subsolid pulmonary nodules. What radiologists need to know.
The small subsolid pulmonary nodules. What radiologists need to know. Poster No.: C-1250 Congress: ECR 2016 Type: Educational Exhibit Authors: L. Fernandez Rodriguez, A. Martín Díaz, A. Linares Beltrán,
More informationGUIDELINES FOR PULMONARY NODULE MANAGEMENT : RECENT CHANGES AND UPDATES
Venice 2017 GUIDELINES FOR PULMONARY NODULE MANAGEMENT : RECENT CHANGES AND UPDATES Heber MacMahon MB, BCh Department of Radiology The University of Chicago Disclosures Consultant for Riverain Medical
More informationLung Neoplasia II Resection specimens Pathobasic. Lukas Bubendorf Pathology
Lung Neoplasia II Resection specimens Pathobasic Lukas Bubendorf Pathology Agenda Preneoplastic lesions Histological subtypes of lung cancer Histological patterns of AC Cells of origin and characteristic
More informationCorrelation in histological subtypes with high resolution computed tomography signatures of early stage lung adenocarcinoma
Original Article Correlation in histological subtypes with high resolution computed tomography signatures of early stage lung adenocarcinoma Yingying Miao 1,2 *, Jianya Zhang 1,2 *, Jiawei Zou 1,2, Qingqing
More informationApproach to Pulmonary Nodules
Approach to Pulmonary Nodules Edwin Jackson, Jr., DO Assistant Professor-Clinical Director, James Early Detection Clinic Department of Internal Medicine Division of Pulmonary, Allergy, Critical Care and
More informationLung Cancer Screening: To Screen or Not to Screen?
Lung Cancer Screening: To Screen or Not to Screen? Lorriana Leard, MD Co-Director of UCSF Lung Cancer Screening Program Vice Chief of Clinical Activities UCSF Pulmonary, Critical Care, Allergy & Sleep
More informationLung Cancer Diagnosis for Primary Care
Lung Cancer Diagnosis for Primary Care Daniel Nader, DO, FCCP Cancer Treatment Center of America Case 1 In which of the following situations would the U.S. Preventive Services Task Force (USPSTF) recommend
More informationGuidelines for the Management of Pulmonary Nodules Detected by Low-dose CT Lung Cancer Screening
Guidelines for the Management of Pulmonary Nodules Detected by Low-dose CT Lung Cancer Screening 1. Introduction In January 2005, the Committee for Preparation of Clinical Practice Guidelines for the Management
More informationHRCT features distinguishing minimally invasive adenocarcinomas from invasive adenocarcinomas appearing as mixed ground-glass nodules
Original Article HRCT features distinguishing minimally invasive adenocarcinomas from invasive adenocarcinomas appearing as mixed ground-glass nodules Wei Yu 1, Zhaoyu Wang 2, Liyong Qian 2, Shanjun Wang
More informationLearning Objectives. 1. Identify which patients meet criteria for annual lung cancer screening
Disclosure I, Taylor Rowlett, DO NOT have a financial interest /arrangement or affiliation with one or more organizations that could be perceived as a real or apparent conflict of interest in the context
More informationLung Cancer screening :
Lung Cancer screening : Pro-Contra SAMO interdisciplinary workshop on chest tumors 27 and 28 january 2017 Prof L.P.Nicod Sevice de pneumologie CHUV-Lausanne -CH Lung Cancer How big is the problem? Epidemiology
More informationObjectives. Why? Why? Background 11/5/ % incurable disease at presentation Locally advanced disease Metastasis. 14% 5 year survival
Objectives Appraise lung cancer screening trials results Review screening guidelines Lung Cancer Screening: Past, Present and Future Chi Wan Koo, MD Koo.chiwan@mayo.edu Discuss recommendations essential
More informationLung cancer is now a major cause of death in developed
Original Article New IASLC/ATS/ERS Classification and Invasive Tumor Size are Predictive of Disease Recurrence in Stage I Lung Adenocarcinoma Naoki Yanagawa, MD, PhD,* Satoshi Shiono, MD, PhD, Masami Abiko,
More informationThe International Association for the Study of Lung Cancer (IASLC) Lung Cancer Staging Project, Data Elements
Page 1 Contents 1.1. Registration... 2 1.2. Patient Characteristics... 3 1.3. Laboratory Values at Diagnosis... 5 1.4. Lung Cancers with Multiple Lesions... 6 1.5. Primary Tumour Description... 10 1.6.
More informationUpdate on 2015 WHO Classification of Lung Adenocarcinoma 1/3/ Mayo Foundation for Medical Education and Research. All rights reserved.
1 Our speaker for this program is Dr. Anja Roden, an associate professor of Laboratory Medicine and Pathology at Mayo Clinic as well as consultant in the Anatomic Pathology Laboratory and co-director of
More informationUniportal video-assisted thoracoscopic surgery segmentectomy
Case Report on Thoracic Surgery Page 1 of 5 Uniportal video-assisted thoracoscopic surgery segmentectomy John K. C. Tam 1,2 1 Division of Thoracic Surgery, National University Heart Centre, Singapore;
More informationThe revised lung adenocarcinoma classification an imaging guide
Review Article The revised lung adenocarcinoma classification an imaging guide Natasha Gardiner 1, Sanjay Jogai 2, Adam Wallis 3 1 Specialty Registrar in Clinical Radiology, Wessex Deanery, UK; 2 Consultant
More informationPET/CT in lung cancer
PET/CT in lung cancer Andrei Šamarin North Estonia Medical Centre 3 rd Baltic Congress of Radiology 08.10.2010 Imaging in lung cancer Why do we need PET/CT? CT is routine imaging modality for staging of
More informationRadiological staging of lung cancer. Shukri Loutfi,MD,FRCR Consultant Thoracic Radiologist KAMC-Riyadh
Radiological staging of lung cancer Shukri Loutfi,MD,FRCR Consultant Thoracic Radiologist KAMC-Riyadh Bronchogenic Carcinoma Accounts for 14% of new cancer diagnoses in 2012. Estimated to kill ~150,000
More informationStage I synchronous multiple primary non-small cell lung cancer: CT findings and the effect of TNM staging with the 7th and 8th editions on prognosis
Original Article Stage I synchronous multiple primary non-small cell lung cancer: CT findings and the effect of TNM staging with the 7th and 8th editions on prognosis Jingxu Li, Xinguan Yang, Tingting
More informationPathology and Prognosis of Persistent Stable Pure Ground-Glass Opacity Nodules After Surgical Resection
GENERAL THORACIC Pathology and Prognosis of Persistent Stable Pure Ground-Glass Opacity Nodules After Surgical Resection Sukki Cho, MD, HeeChul Yang, MD, Kwhanmien Kim, MD, and Sanghoon Jheon, MD Department
More informationLung /4/18. Please submit all questions concerning the webinar content through the Q&A panel.
Lung NAACCR 2018 2019 WEBINAR SERIES 1 Q&A Please submit all questions concerning the webinar content through the Q&A panel. If you have participants watching this webinar at your site, please collect
More informationImaging Decisions Start Here SM
Owing to its high resolution and wide anatomic coverage, dynamic first-pass perfusion 320-detector-row CT outperforms PET/CT for distinguishing benign from malignant lung nodules, researchers from Japan
More informationOriginal Article Clinical predictors of lymph node metastasis in lung adenocarcinoma: an exploratory study
Int J Clin Exp Med 2016;9(5):8765-8769 www.ijcem.com /ISSN:1940-5901/IJCEM0017315 Original Article Clinical predictors of lymph node metastasis in lung adenocarcinoma: an exploratory study Zhijun Zhu,
More informationEarly-stage locally advanced non-small cell lung cancer (NSCLC) Clinical Case Discussion
Early-stage locally advanced non-small cell lung cancer (NSCLC) Clinical Case Discussion Pieter Postmus The Clatterbridge Cancer Centre Liverpool Heart and Chest Hospital Liverpool, United Kingdom 1 2
More informationWhat to know and what to make of it
Lung Cancer Screening: What to know and what to make of it J. Matthew Reinersman, MD Assistant Professor of Surgery Division of Thoracic and Cardiovascular Surgery Department of Surgery University of Oklahoma
More informationCT findings in multifocal or diffuse non-mucinous bronchioloalveolar carcinoma (BAC)
CT findings in multifocal or diffuse non-mucinous bronchioloalveolar carcinoma (BAC) Poster No.: C-2192 Congress: ECR 2014 Type: Educational Exhibit Authors: I. Sandu, A. R. Popita, I.-A. Brumboiu; Cluj-Napoca/RO
More informationLUNG CANCER SCREENING WHAT S THE IMPACT? Nitra Piyavisetpat, MD Department of Radiology Chulalongkorn University
LUNG CANCER SCREENING WHAT S THE IMPACT? Nitra Piyavisetpat, MD Department of Radiology Chulalongkorn University Objective LDCT lung cancer screening (LCS) Potential Benefits & Harms Recommendation of
More informationCT findings in multifocal or diffuse non-mucinous bronchioloalveolar carcinoma (BAC)
CT findings in multifocal or diffuse non-mucinous bronchioloalveolar carcinoma (BAC) Poster No.: C-2192 Congress: ECR 2014 Type: Educational Exhibit Authors: I. Sandu, A. R. Popita, I.-A. Brumboiu; Cluj-Napoca/RO
More informationWith recent advances in diagnostic imaging technologies,
ORIGINAL ARTICLE Management of Ground-Glass Opacity Lesions Detected in Patients with Otherwise Operable Non-small Cell Lung Cancer Hong Kwan Kim, MD,* Yong Soo Choi, MD,* Kwhanmien Kim, MD,* Young Mog
More informationPrognostic factors in curatively resected pathological stage I lung adenocarcinoma
Original Article Prognostic factors in curatively resected pathological stage I lung adenocarcinoma Yikun Yang 1, Yousheng Mao 1, Lin Yang 2, Jie He 1, Shugeng Gao 1, Juwei Mu 1, Qi Xue 1, Dali Wang 1,
More informationExample of lung screening
Justification of the use of CT for individual health assessment of asymptomatic people How to obtain evidence for IHA - Example of lung screening Mathias Prokop, MD PhD Professor of Radiology Radboud University
More informationLarry Tan, MD Thoracic Surgery, HSC. Community Cancer Care Educational Conference October 27, 2017
Larry Tan, MD Thoracic Surgery, HSC Community Cancer Care Educational Conference October 27, 2017 To describe patient referral & triage for the patient with suspected lung cancer To describe the initial
More informationPrimary Pulmonary Colloid Adenocarcinoma: How Can We Obtain a Precise Diagnosis?
doi: 10.2169/internalmedicine.1153-18 Intern Med 57: 3637-3641, 2018 http://internmed.jp CASE REPORT Primary Pulmonary Colloid Adenocarcinoma: How Can We Obtain a Precise Diagnosis? Shinsuke Ogusu 1, Koichiro
More informationCharacteristics of Subsolid Pulmonary Nodules Showing Growth During Follow-up With CT Scanning
CHEST Original Research Characteristics of Subsolid Pulmonary Nodules Showing Growth During Follow-up With CT Scanning Haruhisa Matsuguma, MD ; Kiyoshi Mori, MD ; Rie Nakahara, MD ; Haruko Suzuki, MD ;
More informationPulmonary Nodules. Michael Morris, MD
Pulmonary Nodules Michael Morris, MD Case 45 year old healthy male Smokes socially Normal physical exam Pre-employment screening remote +PPD screening CXR nodular opacity Case 45 year old healthy male
More informationCharles Mulligan, MD, FACS, FCCP 26 March 2015
Charles Mulligan, MD, FACS, FCCP 26 March 2015 Review lung cancer statistics Review the risk factors Discuss presentation and staging Discuss treatment options and outcomes Discuss the status of screening
More informationSolid part size is an important predictor of nodal metastasis in lung cancer with a subsolid tumor
Cho et al. BMC Pulmonary Medicine (2018) 18:151 https://doi.org/10.1186/s12890-018-0709-2 RESEARCH ARTICLE Solid part size is an important predictor of nodal metastasis in lung cancer with a subsolid tumor
More informationLung imaging. Sebastian Ley 1,2
CLINICAL YEAR IN REVIEW LUNG IMAGING Lung imaging Sebastian Ley 1,2 Affiliations: 1 Dept of Diagnostic and Interventional Radiology, Chirurgische Klinik Dr. Rinecker, Munich, Germany. 2 Dept of Clinical
More informationPredictive risk factors for lymph node metastasis in patients with small size non-small cell lung cancer
Original Article Predictive risk factors for lymph node metastasis in patients with small size non-small cell lung cancer Feichao Bao, Ping Yuan, Xiaoshuai Yuan, Xiayi Lv, Zhitian Wang, Jian Hu Department
More informationFactors that predict lymph node status in clinical stage T1aN0M0 lung adenocarcinomas
Ye et al. World Journal of Surgical Oncology 2014, 12:42 WORLD JOURNAL OF SURGICAL ONCOLOGY RESEARCH Open Access Factors that predict lymph node status in clinical stage T1aN0M0 lung adenocarcinomas Bo
More informationValidation of the T descriptor in the new 8th TNM classification for non-small cell lung cancer
Original Article Validation of the T descriptor in the new 8th TNM classification for non-small cell lung cancer Hee Suk Jung 1, Jin Gu Lee 2, Chang Young Lee 2, Dae Joon Kim 2, Kyung Young Chung 2 1 Department
More informationIASLC 2011/WHO 2015 CLASSIFICATION OF LUNG ADENOCARCINOMAS
Serban Negoita Dylan Holt Marsha Dunn IASLC 2011/WHO 2015 CLASSIFICATION OF LUNG ADENOCARCINOMAS DEMOGRAPHIC PATTERNS, TRENDS, AND IMPLICATIONS FOR CANCER SURVEILLANCE Outline Relevance of lung adenocarcinoma
More informationSteering Committee. Waiting on photo. Paul A. Bunn, Jr., MD Kavita Garg, MD Kim Geisinger, MD Fred R. Hirsch, Gregory Riely, MD, PhD.
Steering Committee Paul A. Bunn, Jr., MD Kavita Garg, MD Kim Geisinger, MD Fred R. Hirsch, Gregory Riely, MD, PhD MD, PhD Waiting on photo Paul Van Schil, MD, PhD William D. Travis, MD Ming-Sound Tsao,
More informationNone
2014 None rosemary clooney Cancer is one of the most common diseases in the developed world: 1 in 4 deaths are due to cancer 1 in 17 deaths are due to lung cancer Lung cancer is the most common
More informationSteering Committee. Waiting on photo. Paul A. Bunn, Jr., MD Kavita Garg, MD Kim Geisinger, MD Fred R. Hirsch, Gregory Riely, MD, PhD.
Steering Committee Paul A. Bunn, Jr., MD Kavita Garg, MD Kim Geisinger, MD Fred R. Hirsch, Gregory Riely, MD, PhD MD, PhD Waiting on photo Paul Van Schil, MD, PhD William D. Travis, MD Ming-Sound Tsao,
More informationNon-Small Cell Lung Carcinoma - Myers
Role of Routine Histology and Special Testing in Managing Patients with Non- Small Cell Lung Carcinoma Jeffrey L. Myers, M.D. A. James French Professor Director, Anatomic Pathology & MLabs University of
More informationUltrasound for Pre-operative Evaluation of Well Differentiated Thyroid Cancer
Ultrasound for Pre-operative Evaluation of Well Differentiated Thyroid Cancer Its Not Just About the Nodes AACE Advances in Medical and Surgical Management of Thyroid Cancer - 2017 Robert A. Levine, MD,
More informationNon Small Cell Lung Cancer Histopathology ד"ר יהודית זנדבנק
Non Small Cell Lung Cancer Histopathology ד"ר יהודית זנדבנק 26.06.09 Lecture outlines WHO histological classification Macro/Micro assessment Early diagnosis Minimal pathology Main subtypes SCC, AdCa, LCLC
More informationBronchioloalveolar carcinoma (BAC) is an imprecise term
Original Article Outcomes of Unresected Ground-Glass Nodules with Cytology Suspicious for Adenocarcinoma Caroline M. Gulati, MD,* Andrew M. Schreiner, MD, Daniel M. Libby, MD,* Jeffrey L. Port, MD, Nasser
More informationHistopathological and CT Imaging Correlation of Various Primary Lung Carcinoma
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 15, Issue 3 Ver. VII (Mar. 2016), PP 104-110 www.iosrjournals.org Histopathological and CT Imaging Correlation
More informationPulmonologist s Perspective
Low-dose CT for lung cancer screening Pulmonologist s Perspective Literature Review Kang-Yun Lee, MD PhD Department of Thoracic Medicine Taipei Medical University- Shuang Ho Hospital Taiwan Local vs. Advanced
More informationShould minimally invasive lung adenocarcinoma be transferred from stage IA1 to stage 0 in future updates of the TNM staging system?
Original Article Should minimally invasive lung adenocarcinoma be transferred from stage to stage 0 in future updates of the TNM staging system? Tianxiang Chen 1,2#, Jizhuang Luo 3#, Haiyong Gu 3, Yu Gu
More informationLung Cancers Manifesting as Part-Solid Nodules in the National Lung Screening Trial
Cardiopulmonary Imaging Original Research Yip et al. Lung Cancers Manifesting as Part-Solid Nodules Cardiopulmonary Imaging Original Research Rowena Yip 1 Claudia I. Henschke 1 Dong Ming Xu 1 Kunwei Li
More informationobjectives Pitfalls and Pearls in PET/CT imaging Kevin Robinson, DO Assistant Professor Department of Radiology Michigan State University
objectives Pitfalls and Pearls in PET/CT imaging Kevin Robinson, DO Assistant Professor Department of Radiology Michigan State University To determine the regions of physiologic activity To understand
More informationThe IASLC/ATS/ERS classification of lung adenocarcinoma-a surgical point of view
Review Article The IASLC/ATS/ERS classification of lung adenocarcinoma-a surgical point of view Wentao Fang 1, Yangwei Xiang 1, Chenxi Zhong 1, Qunhui Chen 2 1 Department of Thoracic Surgery, 2 Department
More informationCT Screening for Lung Cancer for High Risk Patients
CT Screening for Lung Cancer for High Risk Patients The recently published National Lung Cancer Screening Trial (NLST) showed that low-dose CT screening for lung cancer reduces mortality in high-risk patients
More informationChest imaging III: Nodular pulmonary disease. Ádám Domonkos Tárnoki, MD, PhD Assistant professor Department of Radiology, Semmelweis University 1
Chest imaging III: Nodular pulmonary disease Ádám Domonkos Tárnoki, MD, PhD Assistant professor Department of Radiology, Semmelweis University 1 Pattern 2 Nodular pattern Several round opacity, typically
More informationPET CT for Staging Lung Cancer
PET CT for Staging Lung Cancer Rohit Kochhar Consultant Radiologist Disclosures Neither I nor my immediate family members have financial relationships with commercial organizations that may have a direct
More information8/22/2016. Major risk factors for the development of lung cancer are: Outline
Carcinomas of the Lung: Changes in Staging, Adenocarcinoma Classification and Genetics Grace Y. Lin, M.D., Ph.D. Outline Background Staging of Lung Cancer: Review of the 2010 7 th Edition of the AJCC Cancer
More informationExpert Round Table with Drs. Anne Tsao and Alex Farivar Part 1: Elderly Man with Indolent Bronchioloalveolar Carcinoma
Expert Round Table with Drs. Anne Tsao and Alex Farivar Part 1: Elderly Man with Indolent Bronchioloalveolar Carcinoma February 2010 I d like to welcome everyone, thanks for coming out to our lunch with
More informationInvasive Pulmonary Adenocarcinomas versus Preinvasive Lesions Appearing as Ground-Glass Nodules: Differentiation by Using CT Features 1
Note: This copy is for your personal non-commercial use only. To order presentation-ready copies for distribution to your colleagues or clients, contact us at www.rsna.org/rsnarights. Sang Min Lee, MD
More informationSCBT-MR 2016 Lung Cancer Screening in Practice: State of the Art
SCBT-MR 2016 Lung Cancer Screening in Practice: State of the Art Reginald F. Munden MD, DMD, MBA I have no conflicts of interest to report National Lung Cancer Screening Trial 20% lung cancer mortality
More information3/23/2017. Disclosure of Relevant Financial Relationships. Pathologic Staging Updates in Lung Cancer T STAGE OUTLINE SURVIVAL ACCORDING TO SIZE ONLY
Pathologic Staging Updates in Lung Cancer Disclosure of Relevant Financial Relationships USCAP requires that all planners (Education Committee) in a position to influence or control the content of CME
More informationTHE BENEFITS OF BIG DATA
THE BENEFITS OF BIG DATA Disclosures I am a named inventor on a number of patents and patent applications relating to the evaluation of pulmonary nodules on CT scans of the chest which are owned by Cornell
More informationEvidence based approach to incidentally detected subsolid pulmonary nodule. DM SEMINAR July 27, 2018 Harshith Rao
Evidence based approach to incidentally detected subsolid pulmonary nodule DM SEMINAR July 27, 2018 Harshith Rao Outline Definitions Etiologies Risk evaluation Clinical features Radiology Approach Modifications:
More informationSlide 1. Slide 2. Slide 3. Investigation and management of lung cancer Robert Rintoul. Epidemiology. Risk factors/aetiology
Slide 1 Investigation and management of lung cancer Robert Rintoul Department of Thoracic Oncology Papworth Hospital Slide 2 Epidemiology Second most common cancer in the UK (after breast). 38 000 new
More informationManagement of Multiple Pure Ground-Glass Opacity Lesions in Patients with Bronchioloalveolar Carcinoma
ORIGINAL ARTICLE Management of Multiple Pure Ground-Glass Opacity Lesions in Patients with Bronchioloalveolar Carcinoma Hong Kwan Kim, MD,* Yong Soo Choi, MD,* Jhingook Kim, MD, PhD,* Young Mog Shim, MD,
More informationWhack-a-mole strategy for multifocal ground glass opacities of the lung
Review Article Whack-a-mole strategy for multifocal ground glass opacities of the lung Kenji Suzuki General Thoracic Surgery, Juntendo University School of Medicine, Tokyo, Japan Correspondence to: Kenji
More informationLow-dose CT Lung Cancer Screening Guidelines for Pulmonary Nodules Management Version 2
Low-dose CT Lung Cancer Screening Guidelines for Pulmonary Nodules Management Version 2 The Committee for Management of CT-screening-detected Pulmonary Nodules 2009-2011 The Japanese Society of CT Screening
More informationBest Medical Practices: Maximizing Skills, Minimizing Risk Lung Cancer
Best Medical Practices: Maximizing Skills, Minimizing Risk Lung Cancer Optimal Management of Incidental Pulmonary Nodule Ramin Khorasani, MD, MPH Vice Chair, Department of Radiology Director, Center for
More informationLung Tumor Cases: Common Problems and Helpful Hints
Lung Tumor Cases: Common Problems and Helpful Hints Brandon T. Larsen, MD, PhD Senior Associate Consultant Department of Laboratory Medicine and Pathology Mayo Clinic Arizona Arizona Society of Pathologists
More informationPulmonary adenocarcinoma Issues, Issues and more issues. Why the headache?
Issues Pulmonary adenocarcinoma Issues, Issues and more issues. Why the headache? Classification Multiple nodules Invasive size Alain Borczuk, MD Weill Cornell Medicine Chronic headache - Classification
More informationLung Cancer Imaging. Terence Z. Wong, MD,PhD. Department of Radiology Duke University Medical Center Durham, NC 9/9/09
Lung Cancer Imaging Terence Z. Wong, MD,PhD Department of Radiology Duke University Medical Center Durham, NC 9/9/09 Acknowledgements Edward F. Patz, Jr., MD Jenny Hoang, MD Ellen L. Jones, MD, PhD Lung
More informationAmerican College of Radiology ACR Appropriateness Criteria
American College of Radiology ACR Criteria Radiologic Management of Thoracic Nodules and Masses Variant 1: Middle-aged patient (35 60 years old) with an incidental 1.5-cm lung nodule. The lesion was smooth.
More informationLung Cancer Screening
Scan for mobile link. Lung Cancer Screening What is lung cancer screening? Screening examinations are tests performed to find disease before symptoms begin. The goal of screening is to detect disease at
More informationHow Long Should Small Lung Lesions of Ground-Glass Opacity be Followed?
Original Article How Long Should Small Lung Lesions of Ground-Glass Opacity be Followed? Yoshihisa Kobayashi, MD,* Takayuki Fukui, MD,* Simon Ito, MD,* Noriyasu Usami, MD,* Shunzo Hatooka, MD,* Yasushi
More informationBLADDER CANCER: PATIENT INFORMATION
BLADDER CANCER: PATIENT INFORMATION The bladder is the balloon like organ located in the pelvis that stores and empties urine. Urine is produced by the kidneys, is conducted to the bladder by the ureters,
More informationNovel Asymmetrical Linear Stapler (NALS) for pathologic evaluation of true resection margin tissue
Original Article Novel Asymmetrical Linear Stapler (NALS) for pathologic evaluation of true resection margin tissue Shin-Kwang Kang #, Jin San Bok #, Hyun Jin Cho, Min-Woong Kang Department of Thoracic
More informationAdam J. Hansen, MD UHC Thoracic Surgery
Adam J. Hansen, MD UHC Thoracic Surgery Sometimes seen on Chest X-ray (CXR) Common incidental findings on computed tomography (CT) chest and abdomen done for other reasons Most lung cancers discovered
More informationBasement membrane in lobule.
Bahram Memar, MD Basement membrane in lobule. Normal lobule-luteal phase Normal lobule-follicular phase Lactating breast Greater than 95% are adenocarcinomas in situ carcinomas and invasive carcinomas.
More informationCase Scenario 1. The patient agreed to a CT guided biopsy of the left upper lobe mass. This was performed and confirmed non-small cell carcinoma.
Case Scenario 1 An 89 year old male patient presented with a progressive cough for approximately six weeks for which he received approximately three rounds of antibiotic therapy without response. A chest
More informationLung Cancer Staging: The Revised TNM Classification
Norwegian Society of Thoracic Imaging Oslo, October 2011 Lung Cancer Staging: The Revised TNM Classification Sujal R Desai King s College Hospital, London Lung Cancer The Scale of the Problem Leading cause
More informationImaging in gastric cancer
Imaging in gastric cancer Gastric cancer remains a deadly disease because of late diagnosis. Adenocarcinoma represents 90% of malignant tumors. Diagnosis is based on endoscopic examination with biopsies.
More informationPre-operative Ultrasound of Lymph Nodes in Thyroid Cancer
Pre-operative Ultrasound of Lymph Nodes in Thyroid Cancer AACE - Advances in Medical and Surgical Management of Thyroid Cancer - 2018 Robert A. Levine, MD, FACE, ECNU Thyroid Center of New Hampshire Geisel
More informationRole of CT in Lung Cancer Screening: 2010 Stuart S. Sagel, M.D.
Role of CT in Lung Cancer Screening: 2010 Stuart S. Sagel, M.D. Lung Cancer 219,440 new cases/year in U.S. (2009) 169,390 deaths/year in U.S. mortality greater than from breast, colon, prostate CA combined
More informationLung Cancer Screening. Eric S. Papierniak, DO NF/SG VHA UF Health
Lung Cancer Screening Eric S. Papierniak, DO NF/SG VHA UF Health Overview Background Supporting evidence Guidelines Practical considerations Patient selection What to do with abnormal results Billing/coding
More informationWill CT screening reduce overall lung cancer mortality? Associate Professor of Radiology Department of Medical Imaging UHN / MSH / WCH
Will CT screening reduce overall lung cancer mortality? Heidi Roberts MD FRCP(C) Heidi Roberts, MD, FRCP(C) Associate Professor of Radiology Department of Medical Imaging UHN / MSH / WCH Screening - Requirements
More informationLung Cancer and CT Screening
Lung Cancer and CT Screening Samer Kanaan, MD February 17 th, 2012 Goals Understand the Societal impact of Lung Cancer Identify Risk Factors for Lung Cancer List Diagnostic Tests Available for Lung Cancer
More informationFDG PET/CT STAGING OF LUNG CANCER. Dr Shakher Ramdave
FDG PET/CT STAGING OF LUNG CANCER Dr Shakher Ramdave FDG PET/CT STAGING OF LUNG CANCER FDG PET/CT is used in all patients with lung cancer who are considered for curative treatment to exclude occult disease.
More informationImpact of immunostaining of pulmonary and mediastinal cytology
Impact of immunostaining of pulmonary and mediastinal cytology Harman Sekhon MD, PhD Director of Cytopathology Head of Ottawa-site Ontario Tumour Bank June 20, 2014 Disclaimer Pfizer: Honorarium-Advisory
More information